miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years

<div>Serum levels of miR-155 are not predictive for patients’ overall prognosis. (a) Serum levels of miR-155 were analyzed by qPCR in critically ill patients that survived in the long-term follow-up or succumbed to death. No difference between these groups became apparent. (b) Patients with miR-155 levels below or higher than the median of all patients displayed a similar long-term survival.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years 